STRAGEN NORDIC A/S: Financial statements 2023
CVR: 26717825
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 5,930,803 and a net result of DKK -462,986 compared with DKK -3,257,245 the year before. That is a decrease of 65.7% compared with the year before. Equity in the 2023 report amounted to DKK 6,246,483. The solvency ratio was 23.4%.
- Gross Profit
- DKK 5,930,803
- Profit/Loss
- DKK -462,986
- Equity
- DKK 6,246,483
- Total Assets
- DKK 26,701,616
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 5.9M | -463K | 6.2M | 0 |
| 2022 | - | 17.3M | -3.3M | 6.7M | 0 |
| 2021 | - | 4.3M | 255K | 10M | 6 |
| 2020 | - | 6.8M | 2.6M | 9.7M | 6 |
| 2019 | - | 7M | 1.7M | 7.1M | 6 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 26, 2023, Jean-Yves Paul Etienne Desmottes has joined the board of directors of STRAGEN NORDIC A/S.
As of October 26, 2023, Frank Bouisset has left the board of directors of STRAGEN NORDIC A/S.
STRAGEN NORDIC A/S has published its annual report for 2022. Gross profit came to DKK 17,270,850, and the net result was DKK -3,257,245.
As of June 9, 2023, Antoine Tétard has joined the board of directors of STRAGEN NORDIC A/S.
As of June 9, 2023, Nicholas Stopford has left the board of directors of STRAGEN NORDIC A/S.
As of June 9, 2023, Antoine Tétard is registered as suppleant of STRAGEN NORDIC A/S.
As of June 9, 2023, Nicholas Stopford has stepped down as suppleant of STRAGEN NORDIC A/S.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
